IGF1 and neoplasm: This reduction in the tumor growth by 2-DG could be, in part, due to reduced insulin levels leading to attenuation of the insulin/IGF-1/PI3K/Akt/HIF-1α signaling pathway thereby possibly modulating the various cell cycle regulatory proteins (cyclin D, A, E) involved in the proliferation [55, 56].